Literature DB >> 11399052

Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.

K Fujimoto1, H Sheng, J Shao, R D Beauchamp.   

Abstract

Invasion is a defining event in carcinoma progression. In general, invasive carcinoma is characterized by an epithelial-fibroblastoid conversion associated with loss of cell-cell adhesion receptors such as E-cadherin and beta-catenin. We report here that TGF-beta1 promotes the invasiveness by modulating the alterations of cellular plasticity including a loss of cell-cell contact in Ras-transformed epithelial cells. In order to examine the role of TGF-beta1 in the Ras-induced responses, intestinal epithelial cells expressing a conditionally activated Ha-Ras(Val12) (RIE-iRas cells) were used in this study. Induced expression of activated Ha-Ras(Val12) caused morphologic transformation of the RIE-iRas cells with an increase in vimentin expression and a decrease of E-cadherin levels. There was also redistribution of beta-catenin from the cytoplasm to the nucleus after the induction of Ras. TGF-beta1 treatment enhanced both the decrease in E-cadherin levels and the redistribution of beta-catenin. Interestingly, the activation of Ras markedly decreased the level of TGF-beta receptor type II (TbetaRII) in RIE-iRas cells. However, the expression of plasminogen activator inhibitor-1, which is known to be transcriptionally induced by TGF-beta1, was strongly induced by TGF-beta1 despite the marked downregulation of TbetaRII. The induction of Ha-Ras(Val12) markedly increased the invasiveness in RIE-iRas cells, as evaluated by a collagen type I-coated Boyden-chamber assay, and the Ras-mediated invasiveness was significantly enhanced by TGF-beta1 treatment. Expression of a dominant-negative form of TbetaRII in the RIE-iRas cells abrogated both growth-inhibitory and invasion responses to TGF-beta1. Collectively, these results suggest that TGF-beta1 and oncogenic Ras collaborate in promoting cellular invasiveness in intestinal epithelial cells. The enhancement of invasiveness was correlated with decreased E-cadherin levels and subcellular distribution of beta-catenin. The enhancement of oncogenic Ras-mediated cell transformation by TGF-beta1 occurs via TbetaRII. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11399052     DOI: 10.1006/excr.2000.5229

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  22 in total

1.  Proteomics profiling of Madin-Darby canine kidney plasma membranes reveals Wnt-5a involvement during oncogenic H-Ras/TGF-beta-mediated epithelial-mesenchymal transition.

Authors:  Yuan-Shou Chen; Rommel A Mathias; Suresh Mathivanan; Eugene A Kapp; Robert L Moritz; Hong-Jian Zhu; Richard J Simpson
Journal:  Mol Cell Proteomics       Date:  2010-05-28       Impact factor: 5.911

2.  Epidermal growth factor inhibits glycogen synthase kinase-3 (GSK-3) and beta-catenin transcription in cultured ARPE-19 cells.

Authors:  Walter Krugluger; Stefan Seidel; Kerstin Steindl; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-10       Impact factor: 3.117

3.  Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.

Authors:  Catherine E Gatza; Alisha Holtzhausen; Kellye C Kirkbride; Allyson Morton; Michael L Gatza; Michael B Datto; Gerard C Blobe
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

Review 4.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

5.  Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.

Authors:  Carl E Allen; Jianguo Du; Bo Jiang; Qin Huang; Adam J Yakovich; John A Barnard
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

6.  New specific molecular targets for radio-chemotherapy of rectal cancer.

Authors:  Kristin Snipstad; Christopher G Fenton; Jørn Kjaeve; Guanglin Cui; Endre Anderssen; Ruth H Paulssen
Journal:  Mol Oncol       Date:  2009-11-25       Impact factor: 6.603

7.  Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells.

Authors:  Sarah E Seton-Rogers; Yu Lu; Lisa M Hines; Malvika Koundinya; Joshua LaBaer; Senthil K Muthuswamy; Joan S Brugge
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

8.  Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition.

Authors:  Cindy L Kanies; J Joshua Smith; Christian Kis; Carl Schmidt; Shawn Levy; Khalid S A Khabar; Jason Morrow; Natasha Deane; Dan A Dixon; R Daniel Beauchamp
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

9.  Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids.

Authors:  Richard C Bates; Arthur M Mercurio
Journal:  Mol Biol Cell       Date:  2003-01-26       Impact factor: 4.138

Review 10.  A clinically relevant model of human pancreatic adenocarcinoma identifies patterns of metastasis associated with alterations of the TGF-beta/Smad4 signaling pathway.

Authors:  Shane Holloway; Mishel Davis; Raffat Jaber; Jason Fleming
Journal:  Int J Gastrointest Cancer       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.